Literature DB >> 20462799

Monocytes are resistant to apoptosis in systemic juvenile idiopathic arthritis.

Shivani Srivastava1, Claudia Macaubas, Chetan Deshpande, Heather C Alexander, Sheng-Yung Chang, Yue Sun, Jane L Park, Tzielan Lee, Ann Begovich, Elizabeth D Mellins.   

Abstract

We investigated whether circulating monocytes from patients with systemic juvenile idiopathic arthritis (SJIA) are resistant to apoptosis and which apoptotic pathway(s) may mediate this resistance. A microarray analysis of peripheral blood mononuclear cells (PBMC) of SJIA samples and RT-PCR analysis of isolated monocytes showed that monocytes from active SJIA patients express transcripts that imply resistance to apoptosis. SJIA monocytes incubated in low serum show reduced annexin binding and diminished FasL up-regulation compared to controls. SJIA monocytes are less susceptible to anti-Fas-induced apoptosis and, upon activation of the mitochondrial pathway with staurosporine, show diminished Bid cleavage and Bcl-w down-regulation compared to controls. Exposure to SJIA plasma reduces responses to apoptotic triggers in normal monocytes. Thus, SJIA monocytes are resistant to apoptosis due to alterations in both the extrinsic and intrinsic apoptosis pathways, and circulating factors associated with active SJIA may confer this phenotype.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20462799      PMCID: PMC2902595          DOI: 10.1016/j.clim.2010.04.003

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  64 in total

1.  Significance analysis of microarrays applied to the ionizing radiation response.

Authors:  V G Tusher; R Tibshirani; G Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

Review 2.  The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes.

Authors:  A Alizadeh; M Eisen; R E Davis; C Ma; H Sabet; T Tran; J I Powell; L Yang; G E Marti; D T Moore; J R Hudson; W C Chan; T Greiner; D Weisenburger; J O Armitage; I Lossos; R Levy; D Botstein; P O Brown; L M Staudt
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1999

3.  Resistance to Fas-mediated apoptosis in EBV-infected B cell lymphomas is due to defects in the proximal Fas signaling pathway.

Authors:  A L Snow; L J Chen; R R Nepomuceno; S M Krams; C O Esquivel; O M Martinez
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

4.  Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex.

Authors:  A Krueger; I Schmitz; S Baumann; P H Krammer; S Kirchhoff
Journal:  J Biol Chem       Date:  2001-03-05       Impact factor: 5.157

5.  Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response.

Authors:  Robert A Mitchell; Hong Liao; Jason Chesney; Gunter Fingerle-Rowson; John Baugh; John David; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

6.  Apoptosis of bovine granulosa cells after serum withdrawal is mediated by Fas antigen (CD95) and Fas ligand.

Authors:  C L Hu; R G Cowan; R M Harman; D A Porter; S M Quirk
Journal:  Biol Reprod       Date:  2001-02       Impact factor: 4.285

7.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.

Authors:  A A Alizadeh; M B Eisen; R E Davis; C Ma; I S Lossos; A Rosenwald; J C Boldrick; H Sabet; T Tran; X Yu; J I Powell; L Yang; G E Marti; T Moore; J Hudson; L Lu; D B Lewis; R Tibshirani; G Sherlock; W C Chan; T C Greiner; D D Weisenburger; J O Armitage; R Warnke; R Levy; W Wilson; M R Grever; J C Byrd; D Botstein; P O Brown; L M Staudt
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

8.  The Fas-FasL death receptor and PI3K pathways independently regulate monocyte homeostasis.

Authors:  H Perlman; L J Pagliari; N Nguyen; K Bradley; H Liu; R M Pope
Journal:  Eur J Immunol       Date:  2001-08       Impact factor: 5.532

9.  A novel 5'-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis.

Authors:  R P Donn; E Shelley; W E Ollier; W Thomson
Journal:  Arthritis Rheum       Date:  2001-08

Review 10.  The role of cytokines in monocyte apoptosis.

Authors:  H D Flad; E Grage-Griebenow; F Petersen; B Scheuerer; E Brandt; J Baran; J Pryjma; M Ernst
Journal:  Pathobiology       Date:  1999       Impact factor: 4.342

View more
  11 in total

1.  Alternative activation in systemic juvenile idiopathic arthritis monocytes.

Authors:  Claudia Macaubas; Khoa D Nguyen; Ariana Peck; Julia Buckingham; Chetan Deshpande; Elizabeth Wong; Heather C Alexander; Sheng-Yung Chang; Ann Begovich; Yue Sun; Jane L Park; Kuang-Hung Pan; Richard Lin; Chih-Jian Lih; Erin M Augustine; Carolyn Phillips; Andreas V Hadjinicolaou; Tzielan Lee; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2011-12-28       Impact factor: 3.969

Review 2.  Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions.

Authors:  Elizabeth D Mellins; Claudia Macaubas; Alexei A Grom
Journal:  Nat Rev Rheumatol       Date:  2011-06-07       Impact factor: 20.543

Review 3.  Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart.

Authors:  Yvan Jamilloux; Mathieu Gerfaud-Valentin; Fabio Martinon; Alexandre Belot; Thomas Henry; Pascal Sève
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

4.  Altered signaling in systemic juvenile idiopathic arthritis monocytes.

Authors:  Claudia Macaubas; Elizabeth Wong; Yujuan Zhang; Khoa D Nguyen; Justin Lee; Diana Milojevic; Susan Shenoi; Anne M Stevens; Norman Ilowite; Vivian Saper; Tzielan Lee; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2015-12-31       Impact factor: 3.969

5.  Deficient spontaneous in vitro apoptosis and increased tmTNF reverse signaling-induced apoptosis of monocytes predict suboptimal therapeutic response of rheumatoid arthritis to TNF inhibition.

Authors:  Undine Meusch; Maria Klingner; Christoph Baerwald; Manuela Rossol; Ulf Wagner
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

Review 6.  MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis.

Authors:  Stefano Alivernini; Elisa Gremese; Charles McSharry; Barbara Tolusso; Gianfranco Ferraccioli; Iain B McInnes; Mariola Kurowska-Stolarska
Journal:  Front Immunol       Date:  2018-01-05       Impact factor: 7.561

7.  Antitumor Efficacy of Human Monocyte-Derived Dendritic Cells: Comparing Effects of two Monocyte Isolation Methods.

Authors:  Graça S Marques; Zélia Silva; Paula A Videira
Journal:  Biol Proced Online       Date:  2018-02-02       Impact factor: 3.244

8.  MicroRNA-155 contributes to enhanced resistance to apoptosis in monocytes from patients with rheumatoid arthritis.

Authors:  Megha Rajasekhar; Anton M Olsson; Kathryn J A Steel; Mirella Georgouli; Ushan Ranasinghe; Christine Brender Read; Klaus S Frederiksen; Leonie S Taams
Journal:  J Autoimmun       Date:  2017-01-22       Impact factor: 7.094

9.  Correlation analyses of clinical and molecular findings identify candidate biological pathways in systemic juvenile idiopathic arthritis.

Authors:  Xuefeng B Ling; Claudia Macaubas; Heather C Alexander; Qiaojun Wen; Edward Chen; Sihua Peng; Yue Sun; Chetan Deshpande; Kuang-Hung Pan; Richard Lin; Chih-Jian Lih; Sheng-Yung P Chang; Tzielan Lee; Christy Sandborg; Ann B Begovich; Stanley N Cohen; Elizabeth D Mellins
Journal:  BMC Med       Date:  2012-10-23       Impact factor: 8.775

10.  Immune cell subsets and their gene expression profiles from human PBMC isolated by Vacutainer Cell Preparation Tube (CPT™) and standard density gradient.

Authors:  Christopher P Corkum; Danielle P Ings; Christopher Burgess; Sylwia Karwowska; Werner Kroll; Tomasz I Michalak
Journal:  BMC Immunol       Date:  2015-08-26       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.